Yield10 Bioscience
YTEN
Yield10 Bioscience (YTEN) - Net assets
Net assets on the balance sheet as of December 2023 : -$2.49 M
According to Yield10 Bioscience's latest financial reports the company has -$2.49 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Yield10 Bioscience - Net assets on balance sheet (from 2004 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $4.4 M | -72.54% |
| 2021-12-31 | $16.02 M | 68.13% |
| 2020-12-31 | $9.53 M | -333.34% |
| 2019-12-31 | $-4.09 M | -171.69% |
| 2018-12-31 | $5.69 M | -57.8% |
| 2017-12-31 | $13.5 M | 112% |
| 2016-12-31 | $6.36 M | -51.11% |
| 2015-12-31 | $13.02 M | -30.69% |
| 2014-12-31 | $18.79 M | -7.85% |
| 2013-12-31 | $20.39 M | -56.91% |
| 2012-12-31 | $47.34 M | 19.96% |
| 2011-12-31 | $39.46 M | 66.68% |
| 2010-12-31 | $23.67 M | -56.99% |
| 2009-12-31 | $55.04 M | -6.85% |
| 2008-12-31 | $59.09 M | -33.76% |
| 2007-12-31 | $89.2 M | -18.6% |
| 2006-12-31 | $0.10 B | -335.38% |
| 2005-12-31 | $-46.56 M | 19.47% |
| 2004-12-31 | $-38.98 M | |
| 2002-12-31 | $-1.03 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.88 M | 15.87% | Bahamas |
 NRC Health
NRC | $48.95 M | -2,071.61% | 🇺🇸 USA |